Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
industry-outlook: Archive
OPAL Fuels Inc. (OPAL) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
OPAL FUELS INC (OPAL) delivered earnings and revenue surprises of -150% and 23.75%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
OPALPositive Net Change SNDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Getaround, Inc. (GETR) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Getaround, Inc. (GETR) delivered earnings and revenue surprises of -60% and 44.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GETRPositive Net Change ARBENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Fate Therapeutics (FATE) delivered earnings and revenue surprises of 0% and 140.63%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
FATEPositive Net Change ALLONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Sangamo (SGMO) delivered earnings and revenue surprises of -22.73% and 94.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
SGMOPositive Net Change IMTXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
CarGurus (CARG) Q1 Earnings Top Estimates
by Zacks Equity Research
CarGurus (CARG) delivered earnings and revenue surprises of 10.34% and 0.69%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CARGPositive Net Change MODNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Recursion Pharmaceuticals (RXRX) delivered earnings and revenue surprises of 9.30% and 3.29%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
RXRXNegative Net Change COSMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Array Technologies, Inc. (ARRY) Tops Q1 Earnings Estimates
by Zacks Equity Research
Array Technologies (ARRY) delivered earnings and revenue surprises of 250% and 2.57%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ARRYPositive Net Change NXTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Oncternal Therapeutics (ONCT) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Oncternal Therapeutics (ONCT) delivered earnings and revenue surprises of 1.74% and 223.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ONCTNegative Net Change FENCPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Cutera (CUTR) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Cutera (CUTR) delivered earnings and revenue surprises of 6.42% and 4.38%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CUTRNegative Net Change INLXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Gen Digital (GEN) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Gen Digital (GEN) delivered earnings and revenue surprises of 1.92% and 0.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GENPositive Net Change AIRSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Haynes International (HAYN) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Haynes International (HAYN) delivered earnings and revenue surprises of -23.26% and 5.02%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
HAYNNegative Net Change HYFMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Cambium (CMBM) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Cambium (CMBM) delivered earnings and revenue surprises of -100% and 7.10%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CMBMNegative Net Change DDDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
RB Global (RBA) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
RB Global (RBA) delivered earnings and revenue surprises of 23.29% and 4.84%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
RBAPositive Net Change PAGSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Coherus BioSciences (CHRS) delivered earnings and revenue surprises of -540% and 24.45%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CHRSNegative Net Change RNANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
HireQuest, Inc. (HQI) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
HireQuest (HQI) delivered earnings and revenue surprises of -14.29% and 5.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
HQINegative Net Change YMMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Quest Resource (QRHC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Quest Resource (QRHC) delivered earnings and revenue surprises of 50% and 0.49%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
QRHCNegative Net Change TOMZPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Expensify, Inc. (EXFY) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Expensify (EXFY) delivered earnings and revenue surprises of -37.50% and 6.64%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
EXFYNegative Net Change GBPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Trex (TREX) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Trex (TREX) delivered earnings and revenue surprises of 13.89% and 2.01%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
TREXNegative Net Change SKYNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of 37.84% and 1.32%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ATRANegative Net Change STRONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Issuer Direct Corporation (ISDR) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Issuer Direct (ISDR) delivered earnings and revenue surprises of -72.41% and 19.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ISDRNegative Net Change EOSEPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Arcellx (ACLX) delivered earnings and revenue surprises of 72.55% and 32.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ACLXNegative Net Change LUMONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
UWM Holdings Corporation (UWMC) Reports Break-Even Earnings for Q1
by Zacks Equity Research
UWM (UWMC) delivered earnings and revenue surprises of -100% and 22.13%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
UWMCNegative Net Change BMOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AFC Gamma Inc. (AFCG) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
AFC Gamma (AFCG) delivered earnings and revenue surprises of -2% and 11.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
AFCGNo Net Change CMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Femasys (FEMY) delivered earnings and revenue surprises of 22.73% and 9.67%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
FEMYNegative Net Change ATRANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Perma-Fix Environmental Services, Inc. (PESI) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
PermaFix Environmental Services (PESI) delivered earnings and revenue surprises of 0% and 16.97%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
PESIPositive Net Change DCIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank